Hi all,
I am more than a little sceptical abut Innovative Device programs. Many regulators now have or are intending to implement such programs. In my view they are really about reaction to a general concern about regulations getting in the way of progress. There are two key issues:
- They are likely to be relevant to only a very small number of devices
It's implicit in these kind of programs that the best new devices come from some kind of breakthrough. The reality is that innovation is a continuing and incremental process. The industry in which we all work has developed an astonishing variety of high technology products, and none of that happened overnight. It was the product of continual effort and countless small steps.
- They don't - and in my view should not, lower the regulatory requirements for such devices.
Why should they not lower the bar - well simply, innovative devices are by their very nature less well understood and therefore are more risky. Giving a registration to innovative technology based on a lower requirement is a recipe for a train wreck. One day one of these devices will fail badly and then we will see a backlash.
What the better programs do is offer additional support and guidance to the manufacturers, who are often smaller companies or start ups. And that's a good thing. But maybe that's the issue - should regulators rather than focusing on "Innovative Devices" be putting more into helping smaller "Innovative Companies" understand the regulatory processes?
------------------------------
Arthur Brandwood PhD FRAPS
Founder and Principal Consultant
Brandwood Biomedical
Sydney, Australia
------------------------------
Original Message:
Sent: 31-Jan-2017 15:07
From: Renata Silva
Subject: Definition for Innovative Medical Devices
Dear all,
I am looking for some guidance on whether there is an official definition for innovative medical devices established by local Health Authorities in regulated countries.
Recently in Brazil it was released a guideline from local Health Authority ANVISA defining the need of clinical trials for innovative medical devices. However there is no official definition of innovative MDs in Brazil, therefore we are trying to find official definitions worldwide and benchmark.
Thanks to all, Regards.
------------------------------
Renata Nivoloni de Oliveira Silva MBA RAC
Sao Paulo
Brazil
------------------------------